Department of Pharmaceutical Technology, Federal Fluminense University─UFF, Niteroi, Rio de Janeiro 24241-000, Brazil Institute of Chemistry, Federal Fluminense University─UFF, Niteroi, Rio de Janeiro ...

Knowing foods that cause acid reflux can help you prevent and manage this condition. Common triggers include carbonated drinks, spicy foods, chocolate, and tomatoes. Acid reflux, also known as ...

Lean proteins such as chicken or fish, cooked vegetables, and whole grains are great GERD staples. Low-acid fruits, herbal teas, and plenty of water can also support digestion and soothe symptoms.

Analyst Daina Graybosch of Leerink Partners maintained a Buy rating on Merck & Company (MRK – Research Report), reducing the price target to $119.00. Discover outperforming stocks and invest ...

JPM25 is in full swing as several pharma powerhouses—including Merck, Lilly and Amgen—detail their strategies for growth in the coming year. After an explosive opening marked by a suite of ...

In separate presentations, the CEOs of Bristol Myers Squibb, Pfizer and Merck laid out their plans to overcome high-profile losses of exclusivity (LOEs) slated to dent sales through the end of the ...

Merck & Co. expects to launch an easier-to-administer version of its blockbuster cancer treatment Keytruda before the end of the year, accelerating the company’s efforts to protect its top ...

Executives at Amgen made the case for MariTide’s differentiation, while Merck’s CEO contended that Keytruda’s coming loss of exclusivity can be managed. SAN FRANCISCO — For any hopes the dealmaking ...

Several things can trigger acid reflux or a GERD episode, including some eating habits (like having dinner very late at night) or eating certain foods (like spicy, acidic, or fatty foods).

That’s why essential amino acid deficiencies can negatively affect your entire body, including your nervous, reproductive, immune, and digestive systems. People can have different amino acid ...

Summit Therapeutics (NASDAQ:SMMT), a drug developer challenging pharma giant Merck's (NYSE:MRK) dominance in lung cancer, won a new buy recommendation from Truist on Wednesday based on its deal ...